Masarova, L.; Liu, T.; Fillbrunn, M.; Li, W.; Sajeev, G.; Rao, S.; Gorsh, B.; Signorovitch, J.
Transfusion-Related Cost and Time Burden Offsets in Patients with Myelofibrosis Treated with Momelotinib in the SIMPLIFY-1 and SIMPLIFY-2 Trials. Cancers 2024, 16, 4067.
https://doi.org/10.3390/cancers16234067
AMA Style
Masarova L, Liu T, Fillbrunn M, Li W, Sajeev G, Rao S, Gorsh B, Signorovitch J.
Transfusion-Related Cost and Time Burden Offsets in Patients with Myelofibrosis Treated with Momelotinib in the SIMPLIFY-1 and SIMPLIFY-2 Trials. Cancers. 2024; 16(23):4067.
https://doi.org/10.3390/cancers16234067
Chicago/Turabian Style
Masarova, Lucia, Tom Liu, Mirko Fillbrunn, Weilong Li, Gautam Sajeev, Sumati Rao, Boris Gorsh, and James Signorovitch.
2024. "Transfusion-Related Cost and Time Burden Offsets in Patients with Myelofibrosis Treated with Momelotinib in the SIMPLIFY-1 and SIMPLIFY-2 Trials" Cancers 16, no. 23: 4067.
https://doi.org/10.3390/cancers16234067
APA Style
Masarova, L., Liu, T., Fillbrunn, M., Li, W., Sajeev, G., Rao, S., Gorsh, B., & Signorovitch, J.
(2024). Transfusion-Related Cost and Time Burden Offsets in Patients with Myelofibrosis Treated with Momelotinib in the SIMPLIFY-1 and SIMPLIFY-2 Trials. Cancers, 16(23), 4067.
https://doi.org/10.3390/cancers16234067
